Likewise, in HNSCC, the gain-of-function NSD3 mutations that enhance H3K36 methylation increased tumor growth in xenograft models [57], and the impaired function of NSD3 by H3K36 mutation reduced proliferation of HNSCC cells [89]. This evidence concerns the gene NSD3 and neoplasm.